| Zofran ODT Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Zofran ODT 4 mg | tablet, disintegrating | oral | 1.0 each | OTC |
| Zofran ODT 8 mg | tablet, disintegrating | oral | 1.0 each | OTC |
Posted by jld3 7 months ago
seemed to worsen my severe nausea. i took it 3 times to give it a chance to work, and again, i seemed worse. but I was havi...
MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study - Earthtimes
MonoSol Rx's thin film formulation of ondansetron was studied against GlaxoSmithKline's Zofran ODT(R) product. Based on the results of the study, ...
Thu Feb 21 08:38:55 -0500 2008
FDA approves KV marketing generic drug - Washington Business Journal
Ondansetron is the generic version of GlaxoSmithKline's Zofran ODT tablets, which had US sales of approximately $314 million last yer for the same strengths ...
Tue Jun 26 19:07:41 -0400 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron ... - PharmaLive.com (press release)
Teva's Ondansetron products are AB-rated generic equivalents of GlaxoSmithKline's Zofran(R) Tablets and Zofran(R) ODT, which are indicated for prevention of ...
Tue Jun 26 07:53:31 -0400 2007
ondansetron hydrochloride - The hydrochloride salt of the racemic form of ondansetron, a carbazole derivative and a selective, competitive serotonin 5-HT3 receptor antagonist with antiemetic properties. Although its mechanism of action has not been fully characterized, ondansetron appears to competitively block the action of serotonin at 5HT3 receptors peripherally in the gastrointestinal tract as well as centrally in the area postrema of the CNS (the chemoreceptor trigger zone for vomiting), resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.